Horizon Kinetics Medical ETF

Frequently Asked Questions About MEDX

What does MEDX invest in?

The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic valuation realization and scientific discovery.

What is the expense ratio of MEDX?

Horizon Kinetics Medical ETF (MEDX) charges an expense ratio of 0.85%. This is the annual fee deducted from fund assets to cover management and operations.

How big is MEDX?

Horizon Kinetics Medical ETF (MEDX) manages $17.8M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is MEDX actively managed or an index fund?

MEDX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was MEDX launched?

Horizon Kinetics Medical ETF (MEDX) launched in January 2023 and is managed by Horizon Kinetics.

How has MEDX performed?

MEDX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.